Predictive Clinical Development: De-Risking and Accelerating Clinical Development

For biotech and emerging biopharma companies, every development decision carries significant implications for timelines, funding milestones, and investor confidence. As pressure mounts to advance programs faster, the most successful organizations are using predictive analytics, integrated development planning, and data-driven decision-making to de-risk clinical development and accelerate execution across the entire development lifecycle.

Join this session to learn how biotech sponsors can reduce uncertainty from first-in-human studies through pivotal trials by reducing delays between phases, increasing cross-functional coordination, and improving operational execution to bring therapies to patients faster.

Key Discussion Points:

  • Accelerating transitions between Phase I, II, and III studies
  • Reducing operational “white space” between development milestones
  • Increasing parallelization of clinical, regulatory, and operational workstreams
  • Improving enrollment forecasting and predictability
  • Driving efficiency and speed across the end-to-end development lifecycle

 

INDUSTRY DEBATE Are large CRO operating models equipped to support the agility and priorities of small biotechs?

  • Navigating traditional and niche CRO models as an emerging biotech
  • Understanding the key differences between big pharma and biotech approaches to clinical trial execution and outsourcing strategy
  • Examining how niche and specialist vendors are addressing sponsor pain points with more tailored, flexible solutions
  • Identifying how sponsors and providers can better align expectations, communication models, and operational support for successful partnerships

Breaking Through Silos: Streamlining Site Workflows to Increase Patient Compliance

When managing complex cardiovascular, CNS, and oncology trials, clinical sites often navigate siloed applications to consolidate patient data. This operational burden delays the review of critical patient information, including eCOA completion, sensor data, and consent status, making it harder to identify which patients are falling behind or where immediate action is needed.

In this valuable session, we’ll share a practical roadmap for elevating patient care and reducing site burden. Join us to learn how to optimize clinical workflows, reduce data entry lag, and balance technology needs with real-world site capacity. You’ll discover strategies for using patient adherence data to drive a more efficient and successful trial experience.

 

We’ll explore:

  • How to help site staff spend less time chasing data and more time focused on high-value patient interactions and outcomes
  • Leverage AI and real-time data to gain a holistic view of patient activity, moving from reactive monitoring to proactive care
  • Ways to pinpoint and resolve common trial hurdles with flexible options that reduce burden for both patients and sites
  • Best practices to identify and act on early warning signs of patient disengagement to help protect trial timelines and data quality

INTERACTIVE SESSION The Traps of AI: Misrepresentation, Bias, and the Limits of Existing Data

Opening Question

“If your AI is trained on incomplete data, who is it really working for – and who is it leaving behind?” 

Key Focus Areas

  • How reliance on historical datasets creates systemic gaps, leaving underrepresented groups without sufficient data to ensure accurate AI outputs
  • Exploring the real-world impact of misrepresentation through live audience polling and scenario-based discussions
  • Challenging assumptions: where do we overtrust AI, and how aware are organisations of its limitations?
  • Practical steps to improve outcomes, including how to identify bias and push for more inclusive, representative data

Format

This session will be highly interactive, using live polling, audience Q&A, and scenario-led discussion to test perceptions and uncover blind spots. Attendees will respond to real-world scenarios, compare perspectives across the room, and collectively explore how bias and data gaps influence decision-making in practice.

Resilient Clinical Trial Teams: Using Mindfulness to Improve Focus, Communication, and Quality Under Pressure

Clinical trial teams today operate in increasingly complex, high-pressure environments involving cross-functional coordination, tight timelines, regulatory demands, vendor management, and constant operational decision-making. Over time, sustained cognitive overload and communication strain can impact focus, collaboration, leadership presence, decision-making, and overall quality of execution. This session explores how mindfulness can be practically applied within clinical operations environments to support more effective ways of working in high-demand, fast-paced clinical environments.

This session explores:

  • The science behind mindfulness and its relevance in high-pressure professional environments
  • What mindfulness is and how it supports focus, resilience, communication, and emotional regulation
  • Practical, doable, and immediately applicable mindfulness-based tools that can help clinical operations professionals strengthen focus, communication quality, resilience, decision-making, and sustained performance under pressure
  • This session will end with a group meditation